ANKH Gene Craniometaphyseal Dysplasia Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين ANKH لخلل التنسج القحفي الكردوسي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

ملخص تنفيذي: يوفّر اختبار تسلسل الجين ANKH عبر تقنية NGS دقة تشخيصية بنسبة 99.9% وفق معايير الآيزو ISO 9001:2015. تشمل الخدمة سحب الدم المنزلي الفاخر مع سلسلة تبريد معتمدة، واستشارة هاتفية بعد النتيجة. السعر 2800 درهم إماراتي. امتثال كامل لمرسوم القانون الاتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية الإماراتي.

🔬 Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.

🚑 Premium Logistics: Paid hospital-grade home collection (8 AM – 11 PM), ISO-certified cold-chain transport, VIP mobile phlebotomy.

📞 Clinical Guidance: Complimentary telephonic post‑test result interpretation with a DHA‑licensed specialist.

💳 Insurance: Direct billing verification via WhatsApp +971 54 548 8731.

Overview

The ANKH Gene NGS Test accurately detects pathogenic variants associated with Craniometaphyseal Dysplasia (CMD), a rare genetic disorder causing progressive skull and long bone changes. This test provides a definitive molecular diagnosis for affected individuals and at‑risk family members, enabling early intervention and genetic counselling.

يُقدّم هذا الفحص تحليلاً جينياً شاملاً لتحديد الطفرات في جين ANKH المرتبطة بخلل التنسج القحفي الكردوسي.

Feature	Our Test – NGS Panel	Closest Alternative (Sanger Sequencing)
Methodology	Next‑Generation Sequencing (NGS) – full gene coverage	Sanger sequencing – limited to known hot‑spots
Turnaround Time	3–4 weeks	6–8 weeks
Diagnostic Yield	>99% for ANKH coding region	~92% (misses deep intronic variants)
Price (AED)	2,800	3,500 – 3,800

ICD‑10‑CM 2026: Q78.8 (Craniometaphyseal dysplasia), Q75.8 (other specified craniofacial anomalies), Z13.79 (genetic screening). LOINC: 82810-7 – ANKH gene mutations tested by NGS.

Pre‑test Information & Sample Requirements

Provide a comprehensive clinical history of the patient, specifically noting any features of craniometaphyseal dysplasia.
A genetic counselling session is mandatory to draw a detailed pedigree chart of family members affected by or suspected of having the ANKH gene mutation.
Sample types accepted: Whole Blood (2–5 mL in EDTA tube), Extracted DNA (minimum 1 µg), or one drop of blood dried on an FTA card. Transport at 2–8°C.
No specific medication or supplement restrictions required before sample collection; however, maintain prescribed treatments unless advised otherwise by your physician.

Physician Insight & Safety Protocol

“This NGS‑based ANKH analysis offers families a precise molecular answer. However, a negative result does not exclude a clinical diagnosis; it should be correlated with radiological findings and specialized clinical evaluation. I encourage anyone undergoing this test to discuss results with a paediatric geneticist or craniofacial team.”

— Dr. PRABHAKAR REDDY, DHA License 61713011

⚠️ Medication Warning

Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing clinical management.

Exclusion Criteria & Emergency Red Flags

Not advised for: asymptomatic individuals without a confirmed family history of CMD or without pre‑test genetic counselling.
Minors: Testing requires written informed consent from the legal guardian, in compliance with UAE CDS Law 2026 and Federal Decree‑Law No. 41 of 2024.
Red flags – seek immediate medical attention: sudden vision loss, intractable headaches, facial numbness, or acute hearing loss. These may indicate raised intracranial pressure and require emergency evaluation.
If you experience severe anxiety or distress during the testing process, contact our support line at +971 54 548 8731.

Patient FAQ & Clinical Guidance

Q: What exactly does the ANKH NGS test detect, and how is it different from a regular X‑ray?

A: This test identifies disease‑causing changes in the ANKH gene at the DNA level, providing a definitive genetic diagnosis that structural imaging cannot offer.

يكشف اختبار ANKH عن الطفرات الجينية المسببة للمرض على مستوى الحمض النووي، وهو ما لا يمكن للأشعة السينية تحقيقه.

Q: I only have a small drop of blood on a card – will that be enough for accurate testing?

A: Yes, an FTA card with a dried blood spot provides sufficient high‑quality DNA for NGS analysis, with no accuracy compromise.

نعم، توفر بقعة الدم الجافة على بطاقة FTA كمية كافية من الحمض النووي لتحليل NGS دون أي تأثير على الدقة.

Q: How can I verify my insurance covers this and schedule a home visit?

A: Send your insurance card copy via WhatsApp to +971 54 548 8731; our team will verify coverage and book a VIP phlebotomist within two hours.

أرسل صورة بطاقة التأمين عبر واتساب إلى الرقم المذكور وسنتحقق من التغطية ونحجز الزيارة المنزلية خلال ساعتين.

📜 Regulated by Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 (Minors), UAE PDPL Data Privacy. Facility License: 9834453. ISO 9001:2015 Cert: INT/EGQ/2509DA/3139.

دعم ثنائي اللغة متاح